We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

EUROIMMUN AG

Euroimmun (part of Revvity) is an international provider of medical laboratory products for autoimmune, infection, al... read more Featured Products: More products

Download Mobile App




Multiparametric Serological Testing Aids Diagnosis of Autoimmune Encephalitis

By LabMedica International staff writers
Posted on 09 Dec 2016
Autoimmune encephalitides can manifest with diverse neurological symptoms, including memory deficits, neuropsychiatric conditions and epileptic seizures, and may or may not be associated with cancer.

Timely diagnosis is important, as immediate treatment can prevent irreversible damage to the brain. More...
Particularly in unexplained neurological cases, a comprehensive autoantibody screening can help to establish a diagnosis, enabling rapid commencement of life-saving therapy. Since many of the autoantibody markers are rare, multiparametric screening composed of different transfected-cell substrates is recommended to increase the diagnostic detection rate.

Scientists at the Institute for Experimental Immunology (Euroimmun AG, Lübeck, Germany) tested a cohort that consisted of 2,716 serum samples received between October and December 2010. The samples were tested on a biochip mosaic combining different neuronal tissue sections with monospecific cell substrates for the detection of antibodies against NMDA receptor (NR1), AMPA receptor (GluR1/GluR2), GABAB receptor, LGI1, CASPR2, GAD65, AQP4, and GlyR.

The team found anti-neuronal immunoglobulin G (IgG) in 108 samples with anti-NMDA receptor antibodies being by far the most prevalent finding (38%), followed by anti-LGI1 (11%) and anti-CASPR2 antibodies (11%). In total, more than 60% of the samples were positive for autoantibodies against neuronal surface antigens, while autoantibodies against classical paraneoplastic intracellular antigens were detected in 31%. The high prevalence of autoantibodies against cell surface antigens in CNS underscores the rising relevance of this novel class of neuronal antigens for autoimmune encephalitis diagnostics.

The evaluation of anti-neuronal autoantibodies was then automated using a new function of the established EUROPattern system. The software automatically takes digital images of the substrates and provides a positive/negative classification. The high-resolution images are sharply focussed with the aid of a counterstain, which also serves to verify correct performance of the incubation. The high-quality of the images was verified by comparing on-screen appraisal with visual microscopy using 753 incubations of numerous serum samples sent to a clinical immunology laboratory.

The two evaluation strategies revealed a concordance of 100% with respect to positive/negative discrimination (excluding samples with ambiguous signals at the microscope to avoid inter-reader deviations). The computer-aided immunofluorescence microscopy considerably facilitates the microscopic analysis, supporting laboratory personnel in the rapid issuance of diagnostic findings. This confirmed the high quality of the images and proves that on-screen evaluation offers a satisfying diagnostic accuracy which can compete with classical immunofluorescence microscopy. The study was published originally published on line on August 1, 2016, in the journal Autoimmunity Reviews.

Related Links:
Euroimmun


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Scout\'s patented molecular technology delivers results matching high-complexity PCR 99% of the time (Photo courtesy of Scout Health)

STI Molecular Test Delivers Rapid POC Results for Treatment Guidance

An affordable, rapid molecular diagnostic for sexually transmitted infections (STIs) has the potential to be globally relevant, particularly in resource-limited settings where rapid, point-of-care results... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.